Introduction
============

Neuropathic pain caused by nerve injury remains an intractable disease due to a lack of satisfactory treatment ([@b1-ijmm-41-03-1509]--[@b3-ijmm-41-03-1509]). In 2009, Ciaramitaro *et al* ([@b4-ijmm-41-03-1509]) carried out a multicenter prospective study on the prevalence of neuropathic pain after traumatic brachial plexus injury. From the 107 patients enrolled, 56% had neuropathic pain. Neuropathic pain impaired the quality of life and caused depression. Brachial plexus avulsion (BPA) induces a characteristic persistent oppression and intermittent shooting pain, which is often difficult to cure ([@b5-ijmm-41-03-1509],[@b6-ijmm-41-03-1509]). The pain could be experienced as burning or a feeling of compression. Pain after BPA is resistant to most traditional pain relief treatments ([@b7-ijmm-41-03-1509]) due to a lack of understanding of the cellular or molecular mechanisms in the occurrence and development of pain ([@b8-ijmm-41-03-1509],[@b9-ijmm-41-03-1509]).

As long-term sensitivity changes in neuropathic pain are associated with changes in gene regulation, it is worthy of note to determine if the microRNAs (miRNAs/miRs) that regulate genes taking part in the nociceptive pathways affect the occurrence and development of pain ([@b10-ijmm-41-03-1509]). The key roles of miRNAs in nervous system development and pathophysiology is increasingly evident ([@b11-ijmm-41-03-1509]), however, certain facts remain to be elucidated. Understanding the gene regulatory events in miRNA-mediated neuropathic pain may provide a pathway for identifying biomarkers or finding novel therapeutic targets ([@b12-ijmm-41-03-1509]). Since pathophysiological changes in pain are associated with altered expression in pain-associated proteins, miRNA may be a promising tool for controlling inflammatory and neuropathic pain by regulating gene and protein expression in pain pathways ([@b13-ijmm-41-03-1509]). Few studies have been performed on pain following brachial plexus injury ([@b14-ijmm-41-03-1509]--[@b16-ijmm-41-03-1509]).

In the present study, miRNA expression profiling was performed of the thalamus (T), the anterior cingulate (AC), the dorsal horn of the spinal cord (DHSC) and the blood (B) in a neuropathic pain model 4 weeks after complete brachial plexus avulsion (BPA) surgery. The combination of experimental and bioinformatics methods was applied to identify the biological and cytological functions that were influenced by the changes in miRNA expression ([@b17-ijmm-41-03-1509]). These data provide further evidence in support of the hypothesis that post-complete BPA pain may be regulated by miRNA.

Materials and methods
=====================

Study approval
--------------

Animal handling and procedures used in this study were in agreement with the guidelines of the Animal Care and Use Committee of Fudan University (Shanghai, China). Neuropathic pain was induced in male Sprague-Dawley rats (n=40; weight, 200--250 g; age, 8 weeks; supplied by the Department of Laboratory Animal Science, Fudan University, Shanghai, China) by CBPA. The rats were kept in an environment with a temperature of 20°C and humidity of 50% and were maintained on a 12/12-h light/dark cycle and allowed free access to food and water. The animal use protocol was reviewed and approved by the Animal Ethics and Welfare Committee of Huashan Hospital affiliated to Fudan University.

Animal behavioral tests
-----------------------

### Mechanical allodynia

The rats were placed on a metal mesh floor, covered by a transparent plastic box and raised 30 cm above the floor. The plantar surface of the paw was stimulated with a series of ascending force von Frey monofilaments. The threshold was taken as the lowest force that evoked a brisk withdrawal response to one of five repetitive stimuli ([@b7-ijmm-41-03-1509]). A withdrawal response was considered valid only when the paw was completely removed from the platform.

### Cold allodynia

Cold allodynia was measured by an acetone spray test, as described by Choi *et al* ([@b18-ijmm-41-03-1509]). Briefly, 250 ml acetone was squirted onto the mid-plantar surface of the paw. The withdrawal responses were evaluated on a scale of 0--3 points: 0 points, the paw was not moved; 1 point, a response in which the paw had little or no weight born on it; 2 points, a response in which the paw was elevated and was not in contact with any surface; and 3 points, a vigorous response in which the rat licked, bit or shook the paw.

All behavioral tests were performed by the same technician who was blinded to the study groups and identification of animals in order to avoid subjective differences in interpretation, which could occur with different observers ([@b19-ijmm-41-03-1509]).

Surgery procedure
-----------------

Following the animal behavioral tests, the rats were anesthetized with sodium pentobarbital injected intraperitoneally. The CBPA rat model ([@b20-ijmm-41-03-1509]) was used to induce neuropathic pain. The brachial plexus was approached through a horizontal supraclavicular incision. The sternocleidomastoid muscle was cut off and the omohyoid muscle was pulled aside, leaving the transverse cervical vessels intact. The brachial plexus was located in the scalene fissure, including upper, middle and lower trunks. The complete brachial plexus was grasped with forceps and extracted from the spinal cord by traction. The tissue layers were then brought together and the skin was closed with 4-0 silk sutures.

These rats were maintained on a 12/12 h light/dark cycle and allowed free access to food and water for one month. At the end of the 4 weeks, paw withdrawal threshold to mechanical stimuli was assessed using von Frey filaments and cold allodynia was measured by an acetone spray test, as previously described.

According to the comparison of the behavioral test results (both mechanical allodynia and cold allodynia tests) prior to and following surgery, the rats were divided into two groups: The pain and control group. In the pain group, the paw withdrawal thresholds decreased and cold allodynia points rose following surgery, while the two results did not significantly change following surgery in the control group.

At the completion of behavioral testing, each group (n=3) was euthanized using CO~2~. The flow rate for CO~2~ euthanasia displaced 20% of the chamber volume/min according to the 2013 edition of the American Veterinary Medical Association Guidelines for the Euthanasia of Animals. The following tissues were collected from these rats for microRNA analysis: DHSC, T, AC and B.

miRNA microarray
----------------

Total RNA was isolated using an miRNeasy mini kit and RNase-Free DNase set (both Qiagen, Inc., Valencia, CA, USA). RNA quality was checked with denaturing agarose gel (1.5%) electrophoresis and nucleic acid staining. Samples with 28S and 18S rRNA bands were resolved into two discrete bands that had no significant smearing below each band, and the 28S rRNA band intensity, which was approximately twice that of the 18S rRNA band, was used for subsequent procedures. Total RNA (1 *µ*g) was labeled with Affymetrix^®^ FlashTag™, Biotin HSR RNA Labeling kits (Affymetrix, Inc., Santa Clara, CA, USA). Next, samples were hybridized to a GeneChip^®^ miRNA 4.0 array (Affymetrix, Inc.) at 60 rpm, at 48°C for 16 h. Fluorescent images of microarray slides were scanned using a GeneChip^®^ Scanner 3000 7G (Affymetrix, Inc.). All CEL files from the miRNA 4.0 chips were normalized using Expression Console software (version 1.3.1; Affymetrix, Inc.). Affymetrix miRNA arrays are designed to contain all miRNAs in miRBase release 20 (<http://tools.thermofisher.com/content/sfs/brochures/miRNA_4-0_and_4-1_datasheet.pdf>).

Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) assay
----------------------------------------------------------------------------

All procedures were performed according to the corresponding manufacturer\'s protocols. Expression of the miRNAs was examined with the SYBR-Green RT-PCR kit (Invitrogen; Thermo Fisher Scientific, Inc., Waltham, MA, USA). Results were normalized to U6 expression. RT was performed with 1 mg total RNA using the ThermoScript RT-PCR system (Invitrogen; Thermo Fisher Scientific. Inc.) for first-strand complementary DNA (cDNA) synthesis. For qPCR, cDNA was amplified using the MyiQ Real-Time PCR Detection system (Bio-Rad Laboratories, Inc., Hercules, CA, USA). Quantitative cycle values were obtained from each amplification curve using iQ5 Optical System Software (version 2.1) provided by the manufacturer (Bio-Rad Laboratories, Inc.). The 2^−ΔΔct^ method was used ([@b21-ijmm-41-03-1509]). Primer sequences will be provided upon request. The primers used were as follows: rno-miR-3573-5p forward, 5′-ACACTCCAGCTGGGTGAGGGGCAGTGATAGAAAGGA-3′ and reverese, 5′-CTCAACTGGTGTCGTGGAGTCGGCAATTC AGTTGAGTCCTTTC-3′; rno-miR-3074 forward, 5′-ACACTCCAGCTGGGGATATCAGCTCAGTAGGCACCG-3′ and reverse, CTCAACTGGTGTCGTGGAGTCGGCAATTCAGTTGAGCGGTGCC-3′; rno-miR-25-5p forward, 5′-ACACTCCAGCTGGGAGGCGGAGACACGGGCAATTGC-3′ and reverse, 5′-CTCAACTGGTGTCGTGGAGTCGGCAATTCAGTTGAGGCAATTGC-3′; rno-miR-702-3p forward, 5′-ACACTCCAGCTGGGTGCCCACCCTTTACCCCACTCCA-3′ and reverse, 5′-CTCAACTGGTGTCGTGGAGTCGGCAATTCAGTTGAGTGGAGTG-3′; rno-miR-30c-1-3p forward, 5′-ACACTCCAGCTGGGCTGGGAGAGGGTTGTTTACTCC-3′ and reverse, 5′-CTCAACTGGTGTCGTGGAGTCGGCAATTCAGTTGAGGGAGTAAA-3′; rno-miR-93-3p forward, 5′-ACA CTCCAGCTGGGACTGCTGAGCTAGCACTTCCCGA-3′ and reverse, 5′-CTCAACTGGTGTCGTGGAGTCGGCAATTCAGTTGAGTCGGGAAG-3′; rno-miR-873-5p forward, 5′-ACACTCCAGCTGGGGCAGGAACTTGTGAGTCTCCT-3′ and reverse, 5′-CTCAACTGGTGTCGTGGAGTCGGCAATTCAGTTGAGAGGAGAC-3′; rno-miR-455-3p forward, 5′-ACACTCCAGCTGGGGCAGTCCACGGGCATATA-3′ and reverse, 5′-CTCAACTGGTGTCGTGGAGTCGGCAATTCAGTTGAGAGTGTATA-3′; rno-miR-32-3p forward, 5′-ACACTCCAGCTGGGTGGACGGAGAACTGAT-3′ and reverse, 5′-CTCA ACTGGTGTCGTGGAGTCGGCAATTCAGTTGAGACCCTTAT-3′; rno-miR-184 forward, 5′-ACACTCCAGCTGGGGCAATTTAGTGTGTGTGA-3′ and reverse, 5′-CTCAACTGGTGTCGTGGAGTCGGCAATTCAGTTGAGAATATCAC-3′; universal miR reverse, 5′-TGTCGTGGAGTCGGCAATTC-3′; U6 forward, 5′-CTCGCTTCGGCAGCACATA-3′ and reverse, 5′-ATATGGAACGCTTCACGAATTTGC-3′. The thermocycling conditions were as follows: stage 1 (1 cycle), pre-degeneration at 95°C for 5 sec; stage 2 (40 cycles), denaturation at 95°C for 5 sec and primer annealing at 61°C for 30 sec; stage 3 (1 cycle), sufficient extention at 72°C for 1 min and cooling down at 4-10°C.

Bioinformatic evaluation
------------------------

For the differential regulation miRNAs, the predicted, but not (yet) verified mRNA targets were investigated. Since hundreds were found for each, Gene Ontology (GO) analysis (<http://www.geneontology.org/page/go-database>) was performed using the GO enrichment analysis software tool kit ([@b22-ijmm-41-03-1509],[@b23-ijmm-41-03-1509]) and pathway analysis was performed using Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway/brite/module mapping tools ([@b24-ijmm-41-03-1509]) (<http://www.kegg.jp/kegg/pathway.html#mapping>) to define which gene molecular function terms were enriched that characterize the collection of target genes in comparison with the genome in general.

Statistical analysis
--------------------

Due to the small sample size (n=3), the random variance model t-test was adopted to filter the differentially expressed microRNAs between the control and pain groups using GraphPad 5.0. Following the significance analysis and false discovery rate analysis, differentially expressed genes were selected according to their P-values. P\<0.05 was considered to indicate a statistically significant difference.

Results
=======

miRNA microarray
----------------

To functionally investigate a possible link between miRNA expression and the post-brachial plexus injury neuropathic pain, the differential expression of miRNAs between groups in 4 different tissues, DHSC, T, AC and B, was analyzed. The expression of 728 miRNAs was detected in each tissue and divided into three types according to the changes: Decrease, increase and no change. The statistical results of the microRNA array analysis of the 4 different tissues are shown in [Table I](#tI-ijmm-41-03-1509){ref-type="table"} (P\<0.05; n=3). The statistical analysis software used was GraphPad 5.0.

In the DHSC group, 332 miRNAs exhibited decreased expression, 378 miRNAs exhibited increased expression and 18 miRNAs exhibited no change. The statistical analysis showed that 2 miRNAs were downregulated and 3 miRNAs were upregulated significantly.

In the T group, 305 miRNAs exhibited decreased expression, 409 miRNAs exhibited increased expression and 14 miRNAs exhibited no change. The statistical analysis showed that 13 miRNAs were downregulated and 9 miRNAs were upregulated significantly.

In the AC group, 348 miRNAs exhibited decreased expression, 359 miRNAs exhibited increased expression and 21 miRNAs exhibited no change. The statistical analysis showed that 3 miRNAs were downregulated and 9 miRNAs were upregulated significantly.

In the B group, 362 miRNAs exhibited decreased expression, 352 miRNAs exhibited increased expression and 14 miRNAs exhibited no change. The statistical analysis showed that 7 miRNAs were downregulated and no miRNAs were upregulated significantly.

PCR verification
----------------

To validate the microarray results, RT-qPCR was performed for these differentially regulated (diff-reg) miRNAs in the 4 groups. It was found that the relative expression of 10 miRNAs among them were significantly altered, which coincided with the results of the microarray. The 10 miRNAs were miR-3573-5p (DHSC), miR-3074 (DHSC), miR-30c-1-3p (AC and T), miR-702-3p (AC), miR-184 (AC), miR-25-5p (AC), miR-873-5p (T), miR-93-3p (T), miR-455-3p (B) and miR-32-3p (B). miR-30c-1-3p with a significant change appeared in both the AC and T groups. The other miRNAs could not be verified by PCR. The statistical analysis showed that miR-3573-5p (DHSC), miR-3074 (DHSC), miR-455-3p (B) and miR-32-3p (B) were downregulated, and that miR-30c-1-3p (AC and T), miR-702-3p (AC), miR-184 (AC), miR-25-5p (AC), miR-873-5p (T) and miR-93-3p (T) were upregulated significantly ([Table II](#tII-ijmm-41-03-1509){ref-type="table"}).

Bioinformatics analysis of the diff-reg miRNAs
----------------------------------------------

For these diff-reg miRNAs with PCR verification, the predicted, but not (yet) verified, mRNA targets were investigated.

In the DHSC group, there were 27 intersection genes ([Table III](#tIII-ijmm-41-03-1509){ref-type="table"}), which were involved in neuropathic pain according to GO and pathway analyses. GO analysis showed that the downregulation function of miR-3573-5p and miR-3074 associated with neuropathic pain included \'axon guidance\', \'synaptic transmission\', \'synapse maturation\', \'excitatory post-synaptic membrane potential\', \'neuron apoptotic process\', \'macrophage activation involved in immune response\', \'cell chemotaxis\', \'neuron migration\' and \'neuron differentiation\'. The target genes of miR-3573-5p and miR-3074 took part in several pathways, including the \'calcium signaling pathway\', \'cholinergic synapse\', \'GABAergic synapse\', \'glutamatergic synapse\', the \'HIF-1 signaling pathway\', the \'MAPK signaling pathway\', the \'mTOR signaling pathway\', the \'notch signaling pathway\', the \'PI3K-Akt signaling pathway\', \'synaptic vesicle cycle\' and the \'Wnt signaling pathway\'. Downregulation of miR-3573-5p and miR-3074 would result in upregulation of the target genes, which inhibited neuron apoptotic process, promoted long-term potentiation and synapse plasticity, and strengthened cell proliferation and differentiation.

In the T group, there were 3 intersection genes, which were involved in neuropathic pain according to GO and pathway analyses ([Table III](#tIII-ijmm-41-03-1509){ref-type="table"}). GO analysis showed that the upregulation function of miR-30c-1-3p, miR-873-5p and miR-93-3p associated with neuropathic pain included \'neurotransmitter uptake\', \'neuron apoptotic process\', \'sensory perception of pain\', \'long-term memory\' and \'neuron projection development\'. The target genes of miR-30c-1-3p, miR-873-5p and miR-93-3p took part in several pathways, including the \'calcium signaling pathway\', \'cholinergic synapse\', \'dopaminergic synapse\', the \'ErbB signaling pathway\', \'GABAergic synapse\', \'glutamatergic synapse\', the \'hedgehog signaling pathway\', the \'HIF-1 signaling pathway\', \'long-term potentiation\', the \'MAPK signaling pathway\', the \'mTOR signaling pathway\', the \'neurotrophin signaling pathway\', the \'notch signaling pathway\', the \'PI3K-Akt signaling pathway\', \'retrograde endocannabinoid signaling\', \'serotonergic synapse\' and the \'Wnt signaling pathway\'. Upregulation of these miRNAs would result in downregulation of the target genes, which promoted neuron apoptotic apoptosis, reduced long-term potentiation and synapse plasticity, and inhibited cell proliferation and differentiation.

In the AC group, there were 8 intersection genes, which were involved in neuropathic pain according to GO and pathway analyses ([Table III](#tIII-ijmm-41-03-1509){ref-type="table"}). GO analysis indicated that the upregulation function of miR-30c-1-3p, miR-702-3p, miR-184 and miR-25-5p associated with neuropathic pain included \'neuron apoptotic process\', \'regulation of neuronal synaptic plasticity\', \'axon guidance\', \'synaptic transmission (glutamatergic)\', \'axon extension\', \'axonogenesis\', \'long-term synaptic potentiation\', \'sensory perception of pain\', \'response to cold\', \'response to stress\', \'neuron differentiation\', \'neuron migration\', \'neuron cell-cell adhesion\' and \'long-term memory\'. The target genes of miR-30c-1-3p, miR-702-3p, miR-184 and miR-25-5p took part in several pathways, including the \'calcium signaling pathway\', \'cholinergic synapse\', the \'ErbB signaling pathway\', \'GABAergic synapse\', \'glutamatergic synapse\', the \'hedgehog signaling pathway\', the \'HIF-1 signaling pathway\', \'long-term depression\', the \'mTOR signaling pathway\', the \'MAPK signaling pathway\', \'dopaminergic synapse\', \'long-term potentiation\', \'serotonergic synapse\', the \'neurotrophin signaling pathway\', the \'notch signaling pathway\', the \'PI3K-Akt signaling pathway\', \'retrograde endocannabinoid signaling\' and the \'Wnt signaling pathway\'. Upregulation of these miRNAs would result in downregulation of the target genes, which promoted neuron apoptotic apoptosis, reduced long-term potentiation and synapse plasticity, and inhibited cell proliferation and differentiation.

In the B group, there were 3 intersection genes, which were involved in neuropathic pain according to GO and pathway analyses ([Table III](#tIII-ijmm-41-03-1509){ref-type="table"}). GO analysis indicated that the downregulation function of miR-455-3p and miR-32-3p associated with neuropathic pain included \'neuron projection morphogenesis\', \'cell migration\', \'cell proliferation\' and \'apoptotic process\'. The target genes of miR-455-3p and miR-32-3p took part in four pathways: The \'calcium signaling pathway\', the \'HIF-1 signaling pathway\', the \'PI3K-Akt signaling pathway\' and the \'VEGF signaling pathway\'. Downregulation of miR-455-3p and miR-32-3p would induce upregulation of the target genes, which inhibited cell apoptosis, and promoted vascularization, cell migration and proliferation.

In the post-brachial plexus injury neuropathic pain model, the central nerve groups (AC and T) and the peripheral nerve group (DHSC) exhibited contrasting effects on synapse plasticity and neuron apoptosis. The former showed downregulation of synapse plasticity, cell proliferation and differentiation, while the later showed upregulation.

miR-30c-1-3p with a significant change appeared in the AC and T groups, which significantly increased in the pain model. The functions of miR-30c-1-3p associated with neuropathic pain included the \'calcium signaling pathway\', \'cholinergic synapse\', \'dopaminergic synapse\', the \'HIF-1 signaling pathway\', the \'ErbB signaling pathway\', \'long-term potentiation\', the \'neurotrophin signaling pathway\', the \'Wnt signaling pathway\', \'GABAergic synapse\', \'glutamatergic synapse\', the \'MAPK signaling pathway\', the \'mTOR signaling pathway\', \'retrograde endocannabinoid signaling\', \'serotonergic synapse\' and \'long-term depression\'. The predicted genes of miR-30c-1-3p were calcium/calmodulin dependent protein kinase IIβ (Camk2b) and protein kinase Cγ (Prkcg), which were validated by PCR to exhibit significant downregulation in the AC and T groups. Camk2b and Prkcg took part in the \'calcium signaling pathway\' ([www.kegg.jp/dbget-bin/www_bget?map04020](http://www.kegg.jp/dbget-bin/www_bget?map04020); [Fig. 1](#f1-ijmm-41-03-1509){ref-type="fig"}), \'long-term potentiation\' ([www.kegg.jp/dbget-bin/www_bget?map04720](http://www.kegg.jp/dbget-bin/www_bget?map04720); [Fig. 2](#f2-ijmm-41-03-1509){ref-type="fig"}) and \'cholinergic synapse\' ([www.kegg.jp/dbget-bin/www_bget?map04725](http://www.kegg.jp/dbget-bin/www_bget?map04725); [Fig. 3](#f3-ijmm-41-03-1509){ref-type="fig"}). All figures were obtained using the KEGG pathway mapping tool in the KEGG database ([@b24-ijmm-41-03-1509]--[@b26-ijmm-41-03-1509]). The downregulation of Camk2b and Prkcg would inhibit cell proliferation and synapse growth protein formation, which made synapse plasticity decrease.

Discussion
==========

It has previously been revealed that descending facilitatory modulation is a key mechanism underlying the induction and maintenance of neuropathic pain ([@b27-ijmm-41-03-1509]). It is well documented that spinal nociception is powerfully modulated by an endogenous descending inhibitory system ([@b27-ijmm-41-03-1509]), although descending control is bi-directional via inhibitory and facilitatory systems. When the brachial plexus was avulsed, the peripheral nerves were separated from the DHSC, which resulted in blockage of the descending inhibitory system. Sustained activation of descending facilitation increased the excitability of spinal nociceptive neurons and promoted long-term potentiation and synapse plasticity, which in turn evoked neuroplasticity of certain supraspinal structures, including the anterior cingulate cortex (ACC) and rostral ventral medulla ([@b8-ijmm-41-03-1509]--[@b30-ijmm-41-03-1509]), which underly certain states of neuropathic pain.

The roles of the ACC and T in pain conditions have been consistently demonstrated for the past several decades ([@b31-ijmm-41-03-1509],[@b32-ijmm-41-03-1509]). Numerous animal studies have been performed to identify the T and ACC as potential mediators of the pain experience, which are not only involved in the transmission of pain sensation, but also serve a role in processing pain-related emotions ([@b27-ijmm-41-03-1509]). The ACC and T widely connect with the descending modulation system.

However, the miRNAs within the ACC and T that mediated the perception of nociceptive signals following brachial plexus injury remain poorly understood. In the present study, 4 miRNAs in the ACC and 3 miRNAs in the T exhibited significant upregulation, and were associated with neuropathic pain. The functions of the miRNAs in the ACC and T were synergetic in the aspect of positive regulation of neuron apoptotic process, and inhibition of long-term potentiation and synapse plasticity. Previous studies reported that peripheral injury induced long-term potentiation of excitatory synaptic responses in the ACC neurons ([@b33-ijmm-41-03-1509],[@b34-ijmm-41-03-1509]).

miR-30c-1-3p and its predicted genes (Camk2b and Prkcg) existed in the AC and T groups, with significant changes, in the present study. Waggener *et al* ([@b35-ijmm-41-03-1509]) reported that calmodulin-dependent protein kinase II regulated oligodendrocyte maturation and central nervous system myelination. Fang *et al* ([@b36-ijmm-41-03-1509]) reported that Camk2b protected neurons from homocysteine-induced apoptosis with the involvement of the hypoxia-inducible factor 1α signal pathway. Miletic *et al* ([@b37-ijmm-41-03-1509]) demonstrated that Prkcg mediated the phosphorylation of glutamate receptor 1 in the postsynaptic density of spinal dorsal horn neurons, accompanied with neuropathic pain. Yeh *et al* ([@b38-ijmm-41-03-1509]) observed the expression of dorsal spinal protein kinase C γ-subunit and other pain-related molecules in the spinal area in neuropathic pain model animals. Together, these studies indicated that miR-30c-1-3p may serve an extremely important role in neuropathic pain.

Besides central sensitization, peripheral sensitization is also associated with neuropathic pain following brachial plexus avulsion, which may result from ectopic discharge ([@b39-ijmm-41-03-1509]), scar stimulation ([@b40-ijmm-41-03-1509]) and excitory conduction short circuit due to the lack of myelin sheaths, among others ([@b41-ijmm-41-03-1509]). The concrete mechanisms of these causes include five aspects: Neuronal apoptosis, axonal regeneration, immune cell infiltration, glial cell accumulation and chemokine transfer ([@b42-ijmm-41-03-1509]). The present study indicated that 2 microRNAs in the DHSC group and 2 microRNAs in the B group exhibited significant down-regulation in the pain model. GO analysis showed that these microRNAs had functions in \'axon guidance\', \'synaptic transmission\', \'synapse maturation\', \'excitatory postsynaptic membrane potential\', \'the neuronal apoptotic process\', \'macrophage activation involved in the immune response\', \'cell chemotaxis\', \'neuron migration\' and \'neuron differentiation\', \'neuron projection morphogenesis\', \'cell migration\', \'cell proliferation\' and \'apoptosis\', which facilitated the peripheral sensitization and induced neuropathic pain. The functions of the microRNAs in the DHSC and B groups were synergetic in the aspect of inhibition of cell apoptosis and promotion of cell proliferation, which contrasted with the functions of the differentially expressed miRNAs in the AC and T groups. When sustained activation of descending facilitation system occurred, a number of neurotrophic factors and neurotransmitters were exhausted and synapse growth proteins decreased, which resulted in neuron apoptosis increasing and synapse plasticity decreasing in the AC and T.

There were 10 miRNAs with significant expressional changes in the pain group, namely miR-3573-5p (DHSC), miR-3074 (DHSC), miR-30c-1-3p (AC and T), miR-702-3p (AC), miR-184 (AC), miR-25-5p (AC), miR-873-5p (T), miR-93-3p (T), miR-455-3p (B) and miR-32-3p (B). Previous studies on the aforementioned miRNAs associated with neuropathic pain have included a study by Lu *et al* ([@b43-ijmm-41-03-1509]), which found that miR-702-3p was differentially expressed in rat cortex in the anesthetic treatment group, which indicated the miRNA may be associated with neuropathic pain. McAdams *et al* ([@b44-ijmm-41-03-1509]) reported that morphine decreased the expression of miR-455-3p in the hippocampus of stressed neonatal mice and that the miRNA was involved in neurodevelopment, neurotransmission and inflammation. Gong *et al* ([@b45-ijmm-41-03-1509]) investigated the differentially expressed miRNAs in the lumbar spinal dorsal horn of mice with streptozotocin-induced diabetic neuropathic pain (DNP) and found that aberrant expression of miR-184 may contribute to the pathogenesis of DNP, and was a potential target for therapeutic interventions following DNP. McKiernan *et al* ([@b46-ijmm-41-03-1509]) identified miR-184 as a novel contributor to neuronal survival following mild and severe seizures. Furthermore, Liu *et al* ([@b47-ijmm-41-03-1509]) found that high levels of miR-184 promoted proliferation, but inhibited differentiation of adult neural stem/progenitor cells, and that the miRNA regulated the expression of numblike, a known regulator of brain development.

In future research, the predicted genes (Camk2b and Prkcg) should be verified as the targets of miR-30c-1-3p by cytology. miR-30c-1-3p could be transfected into neuron cells through plasmids and then the amount of target proteins could be measured by PCR and western blot analysis. If Camk2b and Prkcg were validated as the targets of miR-30c-1-3p, an attempt would be made to inject an miR-30c-1-3p-expressing virus into the ACC of the rat and then behavioral tests would be performed to determine whether the rat was in pain or not.

In conclusion, in the present study, post-CBPA pain was regulated intricately by miRNAs from different tissues in different pathways. There were 10 miRNAs with significant changes in expression in 4 different tissues in the post-BPA pain model. The central nerve groups (AC and T) and the peripheral nerve groups (DHSC) exhibited contrasting effects on synapse plasticity and neuron apoptosis. miR-30c-1-3p and its predicted genes (Camk2b and Prkcg) existed in the AC and T groups with significant espressional changes.
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###### 

miRNAs with statistical differences in expression between the pain and control groups.

  miRNA            P-value    FDR     Fold-change   Regulation trend   Sequence length, nt   Sequence (5′-3′)
  ---------------- ---------- ------- ------------- ------------------ --------------------- --------------------------
  DHSC group                                                                                 
   miR-3573-5p     0.0068     1.000   0.70          Down               22                    UGAGGGGCAGUGAUAGAAAGGA
   miR-3074        0.041413   1.000   0.90          Down               22                    GAUAUCAGCUCAGUAGGCACCG
   miR-1193-3p     0.025148   1.000   1.23          Up                 22                    UAGGUCACCCGUUUUACUAUCC
   miR-410-5p      0.040567   1.000   1.23          Up                 21                    AGGUUGUCUGUGAUGAGUUCG
   miR-340-5p      0.018692   1.000   1.48          Up                 22                    UUAUAAAGCAAUGAGACUGAUU
  AC group                                                                                   
   miR-208a-3p     0.018404   0.997   0.37          Down               18                    AUAAGACGAGCAAAAAGC
   miR-6216        0.028229   0.997   0.71          Down               23                    GAUACACAGAGGCAGGAGGAGAA
   miR-3580-3p     0.034532   0.997   0.72          Down               22                    UGACUAGGGUAGUAUGAGUAGA
   miR-205         0.045209   0.997   1.41          Up                 23                    UCCUUCAUUCCACCGGAGUCUGU
   miR-25-5p       0.030307   0.997   1.46          Up                 22                    AGGCGGAGACACGGGCAAUUGC
   miR-702-3p      0.035705   0.997   1.49          Up                 23                    UGCCCACCCUUUACCCCACUCCA
   miR-501-3p      0.024475   0.997   1.65          Up                 23                    AAUGCACCCGGGCAAGGAUUUGG
   let-7f-5p       0.035378   0.997   1.70          Up                 22                    UGAGGUAGUAGAUUGUAUAGUU
   miR-381-5p      0.032536   0.997   1.80          Up                 22                    AGCGAGGUUGCCCUUUGUAUAU
   miR-30c-1-3p    0.011214   0.997   1.87          Up                 22                    CUGGGAGAGGGUUGUUUACUCC
   miR-671         0.028852   0.997   1.87          Up                 21                    UCCGGUUCUCAGGGCUCCACC
   miR-184         0.006879   0.997   2.42          Up                 22                    UGGACGGAGAACUGAUAAGGGU
  T group                                                                                    
   miR-34b-5p      0.04851    0.971   0.62          Down               23                    AGGCAGUGUAAUUAGCUGAUUGU
   miR-181d-3p     0.0342     0.971   0.65          Down               20                    CCACCGGGGGAUGAAUGUCA
   miR-484         0.027441   0.971   0.66          Down               22                    UCAGGCUCAGUCCCCUCCCGAU
   miR-370-5p      0.016922   0.971   0.70          Down               24                    CAGGUCACGUCUCUGCAGUUACAC
   miR-9b-5p       0.008269   0.971   0.78          Down               19                    UUCGGUUAUCUAGCUUUAU
   miR-1912-3p     0.017277   0.971   0.79          Down               19                    CACAGAACAUGCAGUGAGA
   miR-759         0.018461   0.971   0.81          Down               22                    GCAGAGUGCAAACAAUUUUGAC
   miR-463-5p      0.036635   0.971   0.81          Down               21                    UACCUAAUUUGUUGUCCAUCA
   miR-193-3p      0.045474   0.971   0.81          Down               22                    AACUGGCCUACAAAGUCCCAGU
   miR-802-5p      0.040079   0.971   0.83          Down               21                    UCAGUAACAAAGAUUCAUCCU
   miR-218a-5p     0.019683   0.971   0.84          Down               21                    UUGUGCUUGAUCUAACCAUGU
   miR-31b         0.031174   0.971   0.84          Down               19                    CUAUGCCAGCAUCUUGCCU
   miR-3593-5p     0.033797   0.971   0.87          Down               22                    UGGCCUCCGCAGGGUUGAAGCU
   miR-3570        0.039038   0.971   1.15          Up                 22                    GGUACAAUCAACGGUCGAUGGU
   miR-3588        0.018922   0.971   1.19          Up                 22                    UCACAAGUUAGGGUCUCAGGGA
   miR-664-3p      0.039461   0.971   1.30          Up                 22                    UAUUCAUUUACUCCCCAGCCUA
   miR-488-3p      0.025485   0.971   1.41          Up                 21                    UUGAAAGGCUGUUUCUUGGUC
   miR-30c-1-3p    0.009129   0.971   2.03          Up                 22                    CUGGGAGAGGGUUGUUUACUCC
   miR-106b-3p     0.018801   0.971   2.08          Up                 22                    CCGCACUGUGGGUACUUGCUGC
   miR-93-3p       0.012217   0.971   2.69          Up                 23                    ACUGCUGAGCUAGCACUUCCCGA
   miR-28-5p       0.041407   0.971   2.85          Up                 22                    AAGGAGCUCACAGUCUAUUGAG
   miR-873-5p      0.02098    0.971   2.93          Up                 21                    GCAGGAACUUGUGAGUCUCCU
  B group                                                                                    
   miR-455-3p      0.028562   0.997   0.32          Down               22                    GCAGUCCACGGGCAUAUACACU
   miR-32-3p       0.030898   0.997   0.47          Down               22                    GCAAUUUAGUGUGUGUGAUAUU
   miR-466b-2-3p   0.032782   0.997   0.57          Down               21                    AUAUACAUACACACAUACACA
   miR-702-3p      0.035054   0.997   0.62          Down               23                    UGCCCACCCUUUACCCCACUCCA
   miR-742-5p      0.035279   0.997   0.72          Down               21                    UACUCACAUGGUUGCUAAUCA
   miR-195-3p      0.021132   0.997   0.73          Down               23                    CCAAUAUUGGCUGUGCUGCUCCA
   miR-509-3p      0.045567   0.997   0.77          Down               22                    UGAUUGACAUGUCUGCAGUGGA

miRNA/miR, microRNA; FDR, false discovery rate; DHSC, dorsal horn of the spinal cord; AC, anterior cingulate; T, thalamus; B, blood.

###### 

miRNAs with differential expression by PCR verification between pain and control groups.

  miRNA               P-value     FDR     Fold-change   Regulation trend   Sequence length, nt   Sequence (5′-3′)
  ------------------- ----------- ------- ------------- ------------------ --------------------- -------------------------
  DHSC group                                                                                     
   rno-miR-3573-5p    0.0067996   1.000   0.70          Down               22                    UGAGGGGCAGUGAUAGAAAGGA
   rno-miR-3074       0.0414127   1.000   0.90          Down               22                    GAUAUCAGCUCAGUAGGCACCG
  AC group                                                                                       
   rno-miR-25-5p      0.0303073   0.997   1.46          Up                 22                    AGGCGGAGACACGGGCAAUUGC
   rno-miR-702-3p     0.0357045   0.997   1.49          Up                 23                    UGCCCACCCUUUACCCCACUCCA
   rno-miR-30c-1-3p   0.0112141   0.997   1.87          Up                 22                    CUGGGAGAGGGUUGUUUACUCC
   rno-miR-184        0.0068785   0.997   2.42          Up                 22                    UGGACGGAGAACUGAUAAGGGU
  T group                                                                                        
   rno-miR-30c-1-3p   0.0091288   0.971   2.03          Up                 22                    CUGGGAGAGGGUUGUUUACUCC
   rno-miR-93-3p      0.0122168   0.971   2.69          Up                 23                    ACUGCUGAGCUAGCACUUCCCGA
   rno-miR-873-5p     0.02098     0.971   2.93          Up                 21                    GCAGGAACUUGUGAGUCUCCU
  B group                                                                                        
   rno-miR-455-3p     0.0285622   0.997   0.32          Down               22                    GCAGUCCACGGGCAUAUACACU
   rno-miR-32-3p      0.0308978   0.997   0.47          Down               22                    GCAAUUUAGUGUGUGUGAUAUU

miRNA/miR, microRNA; FDR, false discovery rate; DHSC, dorsal horn of the spinal cord; AC, anterior cingulate; T, thalamus; B, blood.

###### 

Intersection genes involved in neuropathic pain in GO and pathway analyses.

  Group   Genes
  ------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  DHSC    Grin1, Grm4, Grm6, Itga5, Notch1, P2rx1, Prkcg, Shank1, Peg12, Shank3, Srf, Stx1b, Stxbp1, Syk, Vegfa, Vhl, Wnt8b, Wif1, Adra1b, Cacna1a, Cd38, Chat, Ddit4, Efna2, Fgfr3, Gad1, Gng11
  AC      Camk2b, Csf1, Hdac1, Kdr, Mapk3, Prkcg, Tgfa, Vegfa
  T       Camk2b, Itgb1, Prkcg
  B       Scn1a, Kdr, Nos3

Genes listed belong to the targets of differentially expressed microRNAs according to GO and pathway analyses. GO, Gene Ontology; DHSC, dorsal horn of the spinal cord; AC, anterior cingulate; T, thalamus; B, blood.
